TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35678328 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33657282 — Predictive Biomarker (PRD): BMPER mRNA
Genes: BMPER; KIAA1965
Study 33657282 — Predictive Biomarker (PRD): TMEM43 mRNA
Genes: TMEM43; UNQ2564/PRO6244
Study 33657282 — Predictive Biomarker (PRD): XPC mRNA
Genes: XPC; XPCC
Study 33657282 — Predictive Biomarker (PRD): TOMM40 mRNA
Genes: TOMM40; C19orf1; PEREC1; TOM40
Study 33657282 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34276288 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 33030846 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33030846 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33437904 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 33437904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33437904 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 35719707 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32687612 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study 32687612 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32520623 — Surrogate Endpoint (SUR): Blood pressure
Study 32520623 — Surrogate Endpoint (SUR): Serum potassium
Study 32520623 — Surrogate Endpoint (SUR): Serum creatinine
Study 34856759 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 32677982 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32306943 — Predictive Biomarker (PRD): POMP mRNA
Genes: POMP; C13orf12; UMP1; HSPC014; HSPC036; PNAS-110
Study 35889834 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33335323 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33335323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34836240 — Predictive Biomarker (PRD): 40S ribosomal protein S6
Genes: RPS6; OK/SW-cl.2
Study 33371107 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 35020038 — Surrogate Endpoint (SUR): Bone mineral density
Study 34684312 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34684312 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 34002611 — Surrogate Endpoint (SUR): Blood pressure
Study 34133348 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 33559895 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33390481 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33390481 — Pharmacodynamic Biomarker (PDY): DNA topoisomerase I
Genes: TOP1
Study 36395695 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 32991656 — Predictive Biomarker (PRD): LTB4R mRNA
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 35647831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35647831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35647831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34213061 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 33764994 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 33764994 — Predictive Biomarker (PRD): HSPA5 mRNA
Genes: HSPA5; GRP78
Study 33764994 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 32613329 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33744327 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 33744327 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32140784 — Surrogate Endpoint (SUR): Bone mineral density
Study 35036429 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35036429 — Surrogate Endpoint (SUR): Blood pressure
Study 34965945 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34965945 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34965945 — Predictive Biomarker (PRD): Hormone receptor
Study 36378778 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36378778 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35367070 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 35367070 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 33676590 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35861762 — Surrogate Endpoint (SUR): Blood pressure
Study 34936984 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34936984 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34936984 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32888339 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 35670658 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 34559058 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34559058 — Surrogate Endpoint (SUR): Blood pressure
Study 35026070 — Surrogate Endpoint (SUR): Blood pressure
Study 35183242 — Pharmacodynamic Biomarker (PDY): Nerve excitability testing
Study 36457073 — Surrogate Endpoint (SUR): Blood pressure
Study 33421230 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34536949 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32621877 — Predictive Biomarker (PRD): AZIN2 mRNA
Genes: AZIN2; ADC; KIAA1945; ODCP
Study 32938620 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32938620 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34694437 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34915109 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34915109 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 34654905 — Surrogate Endpoint (SUR): Blood pressure
Study 32347777 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 32347777 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 34871580 — Surrogate Endpoint (SUR): Serum testosterone
Study 35791734 — Predictive Biomarker (PRD): F2RL3 mRNA
Genes: F2RL3; PAR4
Study 33148479 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33148479 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33148479 — Predictive Biomarker (PRD): Hormone receptor
Study 33941921 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33941921 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 33941921 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32172602 — Surrogate Endpoint (SUR): Blood pressure
Study 32469260 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32469260 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 32912274 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 32912274 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32912274 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36366308 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34086514 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33068349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35473348 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34187853 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 36165862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36165862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36165862 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34153543 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 34364385 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 34364385 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 34364385 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34364385 — Predictive Biomarker (PRD): GAS6 mRNA
Genes: GAS6; AXLLG
Study 34364385 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 34364385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34364385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 35500450 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 32033078 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32033078 — Surrogate Endpoint (SUR): Blood pressure
Study 33090910 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34154433 — Safety Biomarker (SAF): Fibroblast growth factor 1
Genes: FGF1
Study 35555099 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DMRT1 mRNA
Genes: DMRT1; DMT1
Study 34453952 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33909773 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33909773 — Surrogate Endpoint (SUR): Blood pressure
Study 33547218 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 33040439 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 33294804 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34949538 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 33834520 — Surrogate Endpoint (SUR): Blood pressure
Study 33059108 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 33059108 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33989767 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33538790 — Predictive Biomarker (PRD): Hormone receptor
Study 34487750 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 34487750 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 33929389 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 32389532 — Surrogate Endpoint (SUR): Blood pressure
Study 35405991 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33184627 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34762376 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 33386898 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33386898 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34265631 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33684086 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 33168806 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34889205 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 34889205 — Predictive Biomarker (PRD): IGFBP2 mRNA
Genes: IGFBP2; BP2; IBP2
Study 32816246 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34637478 — Surrogate Endpoint (SUR): Blood pressure
Study 32651892 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35829980 — Predictive Biomarker (PRD): AZIN2 mRNA
Genes: AZIN2; ADC; KIAA1945; ODCP
Study 33675347 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 32273169 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 35792881 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 35667420 — Safety Biomarker (SAF): Hyaluronic acid
Study 33789284 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33789284 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32539076 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34245777 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34245777 — Safety Biomarker (SAF): BDNF
Study 34570596 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36382358 — Monitoring Biomarker (MOI): HBV DNA
Study 32362229 — Surrogate Endpoint (SUR): Blood pressure
Study 34306189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35294397 — Surrogate Endpoint (SUR): Blood pressure
Study 35114778 — Surrogate Endpoint (SUR): Blood pressure
Study 35114778 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32861428 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 35432560 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32894811 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32894811 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33034707 — Surrogate Endpoint (SUR): Blood pressure
Study 33034707 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32217429 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 35599775 — Predictive Biomarker (PRD): DARS1 mRNA
Genes: DARS1; DARS; PIG40
Study 33021598 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 35285277 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 36112778 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34397332 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 32596297 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study 33744331 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33744331 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 33744331 — Surrogate Endpoint (SUR): Blood pressure
Study 33879535 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33285602 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33285602 — Monitoring Biomarker (MOI): Procalcitonin
Study 33407204 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 34051406 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 36222186 — Predictive Biomarker (PRD): GBP2 mRNA
Genes: GBP2
Study 33010242 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33609066 — Surrogate Endpoint (SUR): Serum potassium
Study 34726661 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34647442 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 33785016 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33758231 — Surrogate Endpoint (SUR): Total kidney volume
Study 32693847 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 36074461 — Surrogate Endpoint (SUR): Blood pressure
Study 36074461 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33495597 — Surrogate Endpoint (SUR): Blood pressure
Study 34436523 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34436523 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 32611242 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32611242 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 33717089 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32217888 — Predictive Biomarker (PRD): ADORA1 mRNA
Genes: ADORA1
Study 32217888 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 32217888 — Predictive Biomarker (PRD): TCL1A mRNA
Genes: TCL1A; TCL1
Study 32217888 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study 33492774 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33847473 — Safety Biomarker (SAF): Hyaluronic acid
Study 32773377 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34395580 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 34395580 — Safety Biomarker (SAF): Hyaluronic acid
Study 33047259 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36084710 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 32297259 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32980290 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34856689 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35500098 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35500098 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35635580 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35635580 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33467421 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 33545749 — Surrogate Endpoint (SUR): Blood pressure
Study 34255199 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 34255199 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 36669426 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34190016 — Surrogate Endpoint (SUR): Blood pressure
Study 32659891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32659891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32659891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34724874 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 34724874 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 36261832 — Surrogate Endpoint (SUR): Blood pressure
Study 35504178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35228783 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 616063474 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 616063474 — Predictive Biomarker (PRD): Hormone receptor
Study 32593322 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32602000 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 32179241 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32179241 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32179241 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32041913 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study 32538746 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 32538746 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 35506388 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35170392 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35170392 — Predictive Biomarker (PRD): MUC2 mRNA
Genes: MUC2; SMUC
Study 33500258 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32468892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35462408 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35906004 — Surrogate Endpoint (SUR): Blood pressure
Study 33410583 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33148672 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 35002557 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 36175919 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 36175919 — Safety Biomarker (SAF): BDNF
Study 32551958 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 33230190 — Predictive Biomarker (PRD): MCCC2 mRNA
Genes: MCCC2; MCCB
Study 33230190 — Pharmacodynamic Biomarker (PDY): Auditory steady-state response
Study 36063826 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33475727 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33761970 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 34063322 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 32424045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35587723 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 35587723 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 35587723 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 36163870 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 36163870 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34362624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34016350 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34016350 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 34016350 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SOD2 mRNA
Genes: SOD2